Anatara Lifesciences (ASX:ANR) Price-to-Operating-Cash-Flow : (As of May. 26, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Price-to-Operating-Cash-Flow?

As of today (2024-05-26), Anatara Lifesciences's share price is A$0.044. Anatara Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01. Hence, Anatara Lifesciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Anatara Lifesciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:ANR's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 26.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Anatara Lifesciences's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 23.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 17.20% per year.

During the past 9 years, Anatara Lifesciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 23.90% per year. The lowest was -108.00% per year. And the median was 7.75% per year.

Anatara Lifesciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Anatara Lifesciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Price-to-Operating-Cash-Flow Chart

Anatara Lifesciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Anatara Lifesciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of Anatara Lifesciences's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Anatara Lifesciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anatara Lifesciences's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anatara Lifesciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Anatara Lifesciences's Price-to-Operating-Cash-Flow falls into.

Anatara Lifesciences Price-to-Operating-Cash-Flow Calculation

Anatara Lifesciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.044	/	-0.012
	=

Anatara Lifesciences's Share Price of today is A$0.044.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anatara Lifesciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Anatara Lifesciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Anatara Lifesciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines